SCHEMBL8053596

SCHEMBL8053596

Cc1cc(C(=O)c2ccc(C(C)C)cc2)[nH]c1CC(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ USP5 P45974 1/20 0.43
▸ AGBL2 Q5U5Z8 1/20 0.39
▸ CYP2C9 P11712 1/20 0.38
▸ ABCB11 O95342 1/20 0.38
▸ PTGS2 P35354 1/20 0.38
▸ CNR1 P21554 1/20 0.37
▸ CNR2 P34972 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ EIF4A3 P38919 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ RXRA P19793 3/20 0.36
▸ POLB P06746 2/20 0.35
▸ RXRB P28702 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ ALKBH5 Q6P6C2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3231863 0.86 PTGS2 (0.44) GAAKDM4EABCB11PTGS2LMNA
SCHEMBL8336761 0.83 GRM5 (0.39) KDM4EAGBL2ABCB11PTGS2MEN1
SCHEMBL8338116 0.77 ALOX15 (0.51) ABCB11PTGS2MAPTMEN1KMT2A
SCHEMBL9724259 0.73 ALDH1A1 (0.43) GAALMNASMN1; SMN2MAPTMEN1
SCHEMBL3992020 0.71 ALDH1A1 (0.41) KDM4ECYP2C9LMNASMN1; SMN2MAPT
SCHEMBL1148332 0.68 CNR1 (0.58) KDM4EUSP5CYP2C9CNR1CNR2
SCHEMBL1127930 0.67 CNR1 (0.54) KDM4EUSP5CYP2C9PTGS2CNR1
SCHEMBL8053588 0.67 USP5 (0.57) GAAKDM4EUSP5AGBL2CYP2C9
SCHEMBL11452308 0.66 CXCL8 (0.44) GAAKDM4EPTGS2LMNASMN1; SMN2
SCHEMBL50522 0.65 ALDH1A1 (0.61) KDM4EUSP5CYP2C9PTGS2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6160003-A 1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia CELL PATHWAYS, INC. (US) 2000-12-12 — — US disclosed
Send feedback